Can tiny blood particles predict rectal cancer outcomes?
NCT ID NCT03874559
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at tiny particles called exosomes in the blood of 30 adults with rectal cancer who are getting chemotherapy and radiation before surgery. The goal is to see if changes in these particles can predict how well the tumor responds to treatment. This is an observational study, not a treatment trial, and aims to improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kansas Medical Center/ Cancer Center
RECRUITINGKansas City, Kansas, 66190, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet and vitamin c supercharge rectal cancer treatment?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Which rectal cancer surgery preserves quality of life better? a study investigates
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- Can AI learn to grade endoscopy quality from video?
- Can precision protons spare rectal cancer patients from harsh side effects?